Person

Enrique A. Conterno

Formerly SVP&Pres, LillyDiab & LillyUSA, Lilly (Eli)

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$7.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • LLY
    Lilly (Eli)
    SVP&Pres, LillyDiab & LillyUSA
    2016 or earlier – last filing Feb 2019

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 15, 2019LLYSale25,000$121.00$3.0M
May 31, 2018LLYSale25,000$85.00$2.1M
May 4, 2017LLYSale25,000$82.76$2.1M

SEC reporting-owner ID (CIK) 1476151 · all filings on EDGAR